IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v473y2011i7348d10.1038_nature10003.html
   My bibliography  Save this article

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

Author

Listed:
  • Scott G. Hansen

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Julia C. Ford

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Matthew S. Lewis

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Abigail B. Ventura

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Colette M. Hughes

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Lia Coyne-Johnson

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Nathan Whizin

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Kelli Oswald

    (AIDS and Cancer Virus Program, SAIC Frederick Inc., National Cancer Institute-Frederick)

  • Rebecca Shoemaker

    (AIDS and Cancer Virus Program, SAIC Frederick Inc., National Cancer Institute-Frederick)

  • Tonya Swanson

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Alfred W. Legasse

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Maria J. Chiuchiolo

    (International AIDS Vaccine Initiative, Vaccine Design and Development Laboratory, 140 58th Street, Building A, Unit 8J, Brooklyn, New York 11220, USA)

  • Christopher L. Parks

    (International AIDS Vaccine Initiative, Vaccine Design and Development Laboratory, 140 58th Street, Building A, Unit 8J, Brooklyn, New York 11220, USA)

  • Michael K. Axthelm

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Jay A. Nelson

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Michael A. Jarvis

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

  • Michael Piatak

    (AIDS and Cancer Virus Program, SAIC Frederick Inc., National Cancer Institute-Frederick)

  • Jeffrey D. Lifson

    (AIDS and Cancer Virus Program, SAIC Frederick Inc., National Cancer Institute-Frederick)

  • Louis J. Picker

    (Vaccine and Gene Therapy Institute, and the Oregon National Primate Research Center, Oregon Health & Science University)

Abstract

Towards T-cell vaccines for HIV/AIDS Following some high-profile clinical trial failures in recent years, the emphasis in HIV/AIDS vaccine research has shifted away from T-cell-based vaccines that control viral replication towards vaccines that block acquisition of infection. Hansen et al. take a novel route to T-cell-based immunity, using cytomegalovirus (CMV) vectors. They find that vaccination with a rhesus-CMV-based vaccine against simian immunodeficiency virus (SIV) provides long-term protection from SIV challenge in rhesus macaques. Protection seems to be mediated by tissue-resident T-effector memory responses, suggesting that persistent vectors such as CMV may be effective in HIV/AIDS vaccines.

Suggested Citation

  • Scott G. Hansen & Julia C. Ford & Matthew S. Lewis & Abigail B. Ventura & Colette M. Hughes & Lia Coyne-Johnson & Nathan Whizin & Kelli Oswald & Rebecca Shoemaker & Tonya Swanson & Alfred W. Legasse &, 2011. "Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine," Nature, Nature, vol. 473(7348), pages 523-527, May.
    • Handle: RePEc:nat:nature:v:473:y:2011:i:7348:d:10.1038_nature10003
    DOI: 10.1038/nature10003
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature10003
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature10003?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fangzhu Zhao & Zachary T. Berndsen & Nuria Pedreño-Lopez & Alison Burns & Joel D. Allen & Shawn Barman & Wen-Hsin Lee & Srirupa Chakraborty & Sandrasegaram Gnanakaran & Leigh M. Sewall & Gabriel Ozoro, 2022. "Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:473:y:2011:i:7348:d:10.1038_nature10003. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.